Skip to main content

Table 1 Reactions to vaccine components in studies with more than 25 participants

From: Vaccination in children with allergy to non active vaccine components

Vaccine component Studies Partecipants, N Allergic reactions N (%)
Egg Measles-mumps-rubella   
    Goodyear-Smith et al. 2005 [9] 73 0 (0%)
    Erlewyn-LajeunesseM et al. 2008 [10] 100.000 42 (0.04%)
    Govindaraj P et al. 2009 [11] 45 0 (0%)
    Cronin J et al. 2012 [12] 310 6 (1.9%)
    Andersen DV et al. 2013 [13] 32 0 (0%)
  Total 100.460 48 (0.04%)
  Influenza   
    Cerecedo C et al. 2007 [27] 26 0 (0%)
    Esposito S et al. 2008 [28] 44 3 (6.8%)
    Chung E et al. 2010 [29] 171 29 (16.9%)
    Gagnon R et al. 2010 [24] 830 9 (1.08%)
    Greenhawt MJ et al. 2010 [30] 105 0 (0%)
    Pien GC et al. 2010 [31] 62 0 (0%)
    Webb et al. 2011 [32] 152 2 (1.3%)
    Erlewyn-Lajeunesse M et al. 2011 [21] 3640 88(2.41%)
    Howe et al. 2011 [25] 135 0 (0%)
    Owens et al. 2011 [33] 64 4 (6.25%)
    Shuler JE et al. 2011 [34] 62 4 (6.4%)
    Fung et al. 2012 [35] 56 2 (3.5%)
    Greenhawt MJ et al. 2012 [26] 105 0 (0%)
    Wainwaring Upton JE et al. 2012 [36] 77 0 (0%)
    Des Roches et al. 2012 [23] 367 13 (3.54%)
    Forsdhal BA et al. 2012 [37] 80 3 (3.75%)
  Total 5982 157 (2.62%)
Yeasts   DiMiceli L et al. 2006 [45] 107 15 (14%)
Dextran   Zanoni G et al. 2008 [62] 100.000 19 (0.01%)
Thimerosal   Wattanakrai P et al. 2007 [72] 46 0 (0%)